Director Ole Isacson resigns from Cyclerion board; replacement to be named

Cyclerion Therapeutics, Inc.

Ole Isacson, M.D., Ph.D., resigned as director effective November 19, 2023.
He served as Chair of Compensation Committee and member of Audit Committee.
No disagreement with Cyclerion on operations, policies, or practices.
Company expects to appoint a new outside director shortly.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Ole Isacson

director

CYCN · Cyclerion Therapeutics, Inc.

Effective: 2023-11-19
Filed: November 24, 2023, 6:59 PM ET

On November 19, 2023, Ole Isacson, M.D., Ph.D., tendered his resignation as a director of Cyclerion Therapeutics, Inc. (the “Company”), effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Ole Isacson resigned as director at Cyclerion Therapeutics, Inc..

Action: resigned
Role: director

Exact text from the filing

On November 19, 2023, Ole Isacson, M.D., Ph.D., tendered his resignation as a director of Cyclerion Therapeutics, Inc. (the “Company”), effective immediately.

View on SEC.gov

Cyclerion Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-23-282705

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.